U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Brookshire Brothers Inc. - 485063 - 12/08/2015
  1. Warning Letters


Brookshire Brothers Inc. MARCS-CMS 485063 —

Brookshire Brothers Inc.

United States

Issuing Office:

United States



Black HHS-Blue FDA Logo



Dallas District Office
4040 N. Central Expressway, Suite 300
Dallas, Texas 75204 

November 21, 2016

UPS Overnight

Jerry Johnson, President & CEO
Brookshire Brothers, Inc.
1201 Ellen Trout Drive
Lufkin, Texas 75904

Dear Mr. Johnson:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter (2016-DAL-WL-06, December 8, 2015). Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.


Shari J. Shambaugh
Director, Compliance Branch
Dallas District Office

Back to Top